Magnesium given in pregnancy reduces the risk of cerebral palsy

January 19, 2025

A new Cochrane meta-analysis has reaffirmed the significant role of magnesium sulfate in reducing the risk of cerebral palsy (CP) and death in preterm infants. This comprehensive review, which analyzed six randomized controlled trials involving nearly 6,000 pregnant participants, provides compelling evidence for the use of this inexpensive intervention in preventing lifelong disability.

The review revealed that magnesium sulfate administration to pregnant women at risk of premature delivery:

*Significantly reduced the risk of CP in children up to 2 years of corrected age (relative risk of 0.71)

*Decreased the combined risk of death or CP (relative risk of 0.87)

*Moderately reduced the risk of severe neonatal intraventricular (brain) hemorrhage

These findings underscore the importance of magnesium sulfate as a neuroprotectant for preterm babies, a recommendation that has been supported by the World Health Organization since 2015.

While not directly related to the CP study, it’s worth noting that magnesium also plays a crucial role in migraine prevention and treatment. Magnesium deficiency, which is present in almost half of migraine sufferers, leads to increased migraine frequency and severity.

Many neurologists recommend magnesium supplements as part of a comprehensive migraine prevention strategy. We sometimes check RBC magnesium levels (the more accurate test than serum levels) before recommending supplementation. Chelated forms of magnesium, such as magnesium glycinate, are better absorbed than magnesium oxide, which is the type most commonly sold in stores. Oral magnesium can help the majority of people who are deficient. About 10%, however, do not absorb oral magnesium. We have these patients come into our clinic for monthly infusions.

Both oral and intravenous magnesium are safe in pregnancy.

However, I have heard some doctors and patients express concern about the harmful effects of magnesium in pregnancy. Indeed, mothers who receive very large amounts of intravenous magnesium (thousands of grams) over a period of more than 5-7 days may deliver babies suffering from osteoporosis, bone fractures, and other problems.

The amount of intravenous magnesium we give our migraine patients is one gram. So, pregnant women can safely take oral magnesium and receive regular intravenous infusions of 1-2 grams of magnesium.

Written by
Alexander Mauskop, MD
Continue reading
September 7, 2025
How Artificial Sweeteners May Be Affecting Your Brain
A large Brazilian study published in Neurology followed nearly 13,000 adults for eight years and found something troubling: people who consumed the most artificial sweeteners showed faster cognitive...
Read article
August 30, 2025
Lithium Levels are low in Alzheimer’s. Is there a role in Migraine and Chronic Pain?
Recently published research on lithium deficiency in Alzheimer’s disease has caught the attention of the media. As a neurologist specializing in pain and headache medicine with an interest in no...
Read article
August 16, 2025
The Healing Power of Holding Hands: Insights from Neuroscience on Pain Relief
There’s something powerful about human touch when you’re hurting. As a neurologist, I see every day how a gentle hand squeeze from someone you trust can shift your pain—not just emotionally, but in...
Read article